Centralised Pan-Algerian Survey on the undertreatment of hypercholesterolemia - CEPHEUS

Study identifier:NIS-CDZ-XXX-2012/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Centralised Pan-Algerian Survey on the undertreatment of hypercholesterolemia

Medical condition

Hypercholesterolemia

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

1236

Study type

Observational

Age

19 Years - 150 Years

Date

Study Start Date: 01 Sept 2010

Primary Completion Date: 01 Mar 2011

Study Completion Date: 01 Mar 2011

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2014 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

Documents available

NIS-CDZ-XXX-2012_1_Synopsis
Download
Trial Results Summaries
Available here

Contacts

Investigators

Principal Investigator

Habib BENNACEUR

AstraZeneca